Keyphrases
ABCA3
34%
Acute Myositis
34%
Amoebic Liver Abscess
34%
Antibiotics
20%
Azithromycin
31%
Blood Coagulation Tests
17%
Caribbean Countries
34%
Case Fatality Rate
27%
Child Self-report
34%
Complete Blood Count
17%
Congenital Pulmonary Malformation
34%
Country Income Level
29%
COVID-19
34%
Degree of Difficulty
17%
Economic Resources
34%
Electron Microscopy
61%
Encephalitis
34%
Eosinophilic Bronchitis
23%
Fistulization
17%
Functional Limitations
23%
Genetic Studies
20%
Gram-positive Bacteria
17%
Hydroxychloroquine
31%
Kidney Involvement
17%
Lamellar Bodies
31%
Latin American
34%
Lung Consolidation
17%
Media Economics
34%
Mucocutaneous Involvement
17%
Multisystemic
17%
Mycoplasma
34%
Mycoplasma Pneumoniae (M. pneumoniae)
23%
Parenchymal Lesions
17%
Pediatric Patients
34%
Pediatric Population
27%
Peru
100%
Peruvian
43%
Pleural Empyema
34%
Pneumonia
34%
Primary Ciliary Dyskinesia
34%
Prior Exposure
17%
Pulmonary Actinomycosis
34%
Pulmonary Surfactant Dysfunction
34%
Respiratory Distress
20%
Response to Treatment
20%
SP-C
34%
Surfactant
34%
Surfactant Dysfunction
20%
Thoracic Actinomycosis
34%
Thrombus
17%
Medicine and Dentistry
Actinomycosis
34%
Adenoviridae
17%
Amoebic Liver Abscess
34%
Antibiotics
20%
Artificial Respiration
23%
Azithromycin
34%
Blood Clotting Test
17%
Bronchiolitis Obliterans
34%
Chest Tube
11%
COVID-19
34%
Dermatosis
17%
Deterioration
11%
Disease
75%
Electrocardiogram
11%
Electron Microscopy
69%
Elevated Transaminases
17%
Encephalitis
34%
Functional Limitation
23%
Genetic Disorder
31%
Guillain-Barré Syndrome
17%
Hydroxychloroquine
34%
Immunoglobulin M
11%
Infection
23%
Intensive Care
17%
Kawasaki Disease
23%
Lamellar Body
34%
Lower Limb
11%
Methylprednisolone
23%
Mosaicism
17%
Mycoplasma
34%
Mycoplasma Pneumonia
23%
Myositis
34%
Neonatal Infant
23%
Orphan Disorder
11%
Pediatrics
66%
Pediatrics Patient
34%
Pleural Empyema
34%
Primary Ciliary Dyskinesia
34%
Pulmonary Actinomycosis
34%
Pulmonary Surfactant
58%
Pulse Rate
23%
Rare Lung Disease
17%
Respiratory Distress
23%
Serositis
34%
Shock (Circulatory)
34%
Surfactant
46%
Surfactant Protein C
34%
Thoracic Wall
11%
Thrombus
17%
Wheeze
17%